Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
Healthy Volunteer
Researchers are evaluating a family-centred approach to prevent cardiovascular diseases CVD among adolescents and their families in Uganda. This 5-year study focuses on reducing risk factors like unhealthy diet and physical inactivity that contribute to CVD and other non-communicable diseases NCDs. The study adapts a proven intervention from Asia to the Ugandan context, aiming to support healthier lifestyle behaviors during the critical adolescence period when habits form that affect adult health. The study includes two groups one receiving the FaCe-D intervention, which involves home visits by Village Health Teams delivering diet, physical activity, and health messaging and a control group receiving standard care with usual health promotion activities. The study is divided into three phases adapting the intervention, implementing it, and evaluating its effectiveness and feasibility in 32 villages. Participants will be involved for at least 12 months, during which researchers will assess changes in cardiovascular health and sleep quality. Evaluations include monitoring behavior changes, health outcomes, and implementation costs. The study also considers adoption and feasibility to understand how well the intervention works in real community settings.
Actively Recruiting
Researchers are evaluating etavopivat in adolescents and adults with sickle cell disease to see if it can reduce vaso-occlusive crises painful blockages in blood vessels and protect organs from damage. This phase 3 study will also assess whether etavopivat improves exercise tolerance and reduces fatigue compared to a placebo. The trial is randomized, double-blind, and placebo-controlled to ensure unbiased results on the medications effects. Participants will be randomly assigned to receive either oral etavopivat or a matching placebo. The study treatment is taken by mouth, and participants will be followed closely for about 2 years. This includes monitoring during the treatment period and ongoing assessments to evaluate the drugs impact on sickle cell disease symptoms and related health measures. Throughout the study, participants will undergo evaluations such as blood tests to measure hemoglobin and other markers, 6-minute walking tests to assess exercise capacity, and fatigue questionnaires. Researchers will track the number of vaso-occlusive crises requiring medical contact over 52 weeks as the primary outcome. Safety and efficacy will be monitored regularly, with follow-up continuing until the study ends approximately 4 years after enrollment begins.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating a novel mobile health information management and communication system called SCD SIMCS for newborn screening of sickle cell disease SCD in Uganda. This cluster randomized trial compares the new system to the routine newborn screening strategy at health care centers. The goal is to measure the impact on screening access, coordination of care, and clinical outcomes for infants with SCD. Health facilities are randomized rather than individuals to avoid contamination and better assess system-level effects. The intervention involves the SCD SIMCS app, which uses artificial intelligence to capture, interpret, and transmit point-of-care test results for sickle cell disease to healthcare providers and a centralized data center at the Uganda Ministry of Health. The app includes modules for capturing infant demographic data, interpreting test images, providing educational videos for counseling, and maintaining a digital health passport with longitudinal clinical information. The comparison group receives the routine newborn screening strategy currently used in Ugandan health centers. Participants include infants born or attending child health and maternity services at selected hospitals, with providers at these centers also involved. Baseline assessments of resources and workflows are conducted before implementing the app. Researchers will monitor outcomes including the number and timeliness of referrals for infants with SCD over 12 months, and adjusted mortality rates over 18 months. The study includes follow-up to evaluate these outcomes and the overall effectiveness of the SCD SIMCS system in improving care coordination and clinical results.